Full Archive

A solution?

As everyone knows our belief is that Tyler – connected insulin pen/cap cover- CGM – app – has the potential to change the diabetes management landscape for patients following multiple daily injection (MDI) therapy. Yet it is also true there are patients who for a wide variety of reasons either do not have access to or do not want to use a CGM. Hence the reason you have so many...

A losing proposition

It’s no shock that when it comes to the toys in the diabetes toy chest there is no shortage of copycat me too toys. The formula is pretty simple actually a market gets developed begins to grow and all of sudden money starts to flow into wannabes. We watched this in the early days of the insulin pump market when everyone wanted to be the next MiniMed. We also watched...

How this will play out

Now that Abbott has countersued Dexcom it’s time to play this out to the end. First and foremost remember how the legal process works. This legal action if it plays out to the very end, which we doubt, will take YEARS. While it may be best for both parties to come to their senses and settle this dispute logic does not always carry the day. As we have said before...

Need your help / New Podcast

Ok we’ve had just about enough of this as we are sick and tired of seeing pictures of a patient pricking their finger to test their glucose. Seriously we all know that BGM is old outdated on its way-out technology being replaced by new state of the art way cool whiz bang CGM technology. Frankly these pictures are not just annoying they are insulting to every patient whose ever used...

The gloves have come off

Perhaps the most undervalued asset in diabetes devices besides a large established user base is a well-protected IP portfolio. Way back in the day Medtronic weaponized their portfolio basically forcing Smith’s Medical to take the Cozmo off the market. Recently Insulet purchased some patents from an old CGM company for both defensive and offensive purposes. And until yesterday Dexcom and Abbott have peacefully co-existed on the IP front. Well the gloves...

Did we learn anything?

Well it’s over and what if anything did we learn from ADA? Or perhaps we should ask the question differently did learn anything new or earth shattering? From our perspective the answer is one big NO. Just to review consider the following- 1. CGM is the most transformative diabetes technology to come along since the discovery of insulin. It’s becoming the standard for glucose measurement and is dramatically changing for the...

Knew this would happen

Today thank goodness is the last day of ADA as this year’s virtual conference came in pretty much as expected, boring. Hopefully next year we will gather in New Orleans and at least share some great gumbo. There was some news today that’s worthy of mentioning only because we just knew it wouldn’t make the insulin cost too much crowd happy. According to one post on CNBC: “Walmart said Tuesday it will...